Clinical Trial Update: Corneal Collagen Cross-linking for Progressive Keratoconus [Phase 3]

View source ↗

Summary

Phase 3 trial for corneal collagen cross-linking in progressive keratoconus completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• Corneal collagen cross-linking (CXL) treatment

Snippet

Sponsor: Glaukos Corporation | Conditions: Progressive Keratoconus | Phase 3 | Status: COMPLETED | Results posted: 2016-07-07